Effects of an Opiod Sparing Care Pathway for Patients undergoing Obesity Surgery

Phase 1

• Conditions: See below; MedDRA version: 21.1Level: LLTClassification code 10059610Term: Obesity surgerySystem Organ Class: 100000004865; Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]

• Registration Number: EUCTR2017-003830-97-SE
• Lead Sponsor: Sahlgrenska University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-12-07
• Last Update Posted: 26 February 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

See below
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 200
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

See below

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: See below;Secondary Objective: Not applicable;Primary end point(s): See below;Timepoint(s) of evaluation of this end point: See below

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): See below;Timepoint(s) of evaluation of this end point: See below